• 1. Synthesis of 2-amino-imidazoles, purines, and benzoxazolamines through DIB oxidation
  Jean-Christophe Andrez RSC Adv. 2012 2 3261

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Carboximidamides
• Solvents and Organic Chemicals Organic Compounds Amines/Sulfonamides

Chloroformamidine hydrochloride (CAS No. 29671-92-9): A Comprehensive Overview

Chloroformamidine hydrochloride, chemically designated as 1-chloro-3-aminomethyl-1,3-propanedione monohydrochloride, is a significant compound in the field of organic synthesis and pharmaceutical research. With a CAS number of 29671-92-9, this compound has garnered attention due to its versatile applications in the development of novel therapeutic agents and biochemical probes. Its unique structural features, including a chlorinated amidine group, make it a valuable intermediate in the synthesis of various bioactive molecules.

The compound's molecular structure consists of a three-carbon backbone with functional groups that facilitate diverse chemical transformations. The presence of a chloroformamidine moiety imparts reactivity that is highly useful in medicinal chemistry, particularly in the construction of heterocyclic frameworks. These frameworks are often integral to the pharmacophores of many drugs used in treating a wide range of diseases.

In recent years, Chloroformamidine hydrochloride has been explored in the context of drug discovery for its potential as a precursor in the synthesis of small-molecule inhibitors. For instance, studies have demonstrated its utility in creating kinase inhibitors, which are critical for targeting cancers and inflammatory diseases. The ability to modify the compound's structure allows researchers to fine-tune its binding properties, enhancing its efficacy as a therapeutic agent.

One notable application of Chloroformamidine hydrochloride is in the development of protease inhibitors. Proteases play a crucial role in various biological processes, and their inhibition is often necessary for treating conditions such as HIV/AIDS and cancer. Researchers have leveraged the compound's reactive sites to design molecules that can selectively inhibit specific proteases, thereby modulating disease pathways.

The synthesis of 1-chloro-3-aminomethyl-1,3-propanedione monohydrochloride involves multi-step organic reactions that highlight its synthetic versatility. The process typically begins with the chlorination of an appropriate precursor, followed by functional group transformations that introduce the amidine moiety. The final step involves salt formation with hydrochloric acid to stabilize the compound for storage and use.

The chemical properties of Chloroformamidine hydrochloride make it an attractive candidate for further derivatization. Its reactivity with nucleophiles allows for the introduction of various substituents, enabling the creation of libraries of compounds for high-throughput screening. This approach has been instrumental in identifying novel drug candidates with improved pharmacokinetic profiles.

In academic research, Chloroformamidine hydrochloride has been employed as a tool compound for studying enzyme mechanisms and interactions. By using labeled or modified versions of this compound, scientists can gain insights into how enzymes recognize and process substrates. These studies not only advance our understanding of fundamental biological processes but also aid in the rational design of enzyme inhibitors.

The pharmaceutical industry has also shown interest in Chloroformamidine hydrochloride due to its potential as an intermediate in large-scale drug production. Its stability under various conditions makes it suitable for industrial processes, where consistency and yield are paramount. Companies are exploring optimized synthetic routes to ensure cost-effective production while maintaining high purity standards.

The safety profile of 1-chloro-3-aminomethyl-1,3-propanedione monohydrochloride is another critical aspect that has been thoroughly evaluated. While handling any chemical requires proper precautions, extensive studies have been conducted to assess its toxicity and environmental impact. These studies have informed guidelines for safe handling and disposal, ensuring that researchers and industrial users can work with the compound without compromising safety.

In conclusion, Chloroformamidine hydrochloride (CAS No. 29671-92-9) is a multifaceted compound with significant applications in pharmaceutical research and drug development. Its unique structural features and reactivity make it a valuable tool for synthesizing bioactive molecules, particularly kinase inhibitors and protease inhibitors. As research continues to uncover new applications for this compound, its importance in advancing medicinal chemistry is likely to grow further.

• 6869-14-3(aminomethanecarbonimidoyl chloride)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)